Li Shuai
Angel Investor @ Northern Light Venture Capital
Li Shuai is a angel investor at Northern Light Venture Capital focused on Robotics and Therapeutics. Li Shuai is the General Manager of Shengshi Hongyuan.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Li Shuai invests in
Stages Li Shuai invests in
Countries Li Shuai invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Robotics 1 (50%)
- Therapeutics 1 (50%)
- Biotechnology 1 (50%)
- Market Research 1 (50%)
- Artificial Intelligence 1 (50%)
Stage
- Angel 1 (50%)
- Series D 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis. | $119.2M / Series D / Sep 09, 2026 | ||
|
Tianyuanxing
|
Tianyuanxing is a general industrial embodied intelligent platform developer whose primary focus is on the research and development of the "TX01" wheeled chassis humanoid dual-arm robot. | $4.4M / Angel / Feb 26, 2026 |
Co-Investors
Gaorong Capital
1 deal together
Beijing Medical and Health Industry Investment Fund
1 deal together
BioVenture
1 deal together
Cornerstone Capital
1 deal together
Northern Light Venture Capital was founded by general partners Feng Deng and Yan Ke on January 1, 2005. Currently it is managed by five Managing Directors. It manages approximately US$ 1.5 billion in committed capital with 4 US$ funds and 4 RMB funds, investing in more than 180 portfolio companies and seed investments to date.NLVC is led by apartnership of accomplished local Chinese and ""returnee"" executives (""returnees"" are those who grew up in mainland China but studied or worked abroad before returning) with significant investing and entrepreneurial accomplishments. Its management team includes Feng Deng, former member of the board at NetScreen (a pioneering IT security firm), Yan Ke, vice President of Netscreen, and Lei Yang, chairman of Vantage Point Venture Partners.NLVC is a China concept venture capital firm focused on early and growth stage opportunities which targets businesses that leverage China’s industrial, economic, or human resources to build exceptional, lasting enterprises in the global economy.NLVC focuses on early and growth stage opportunities in information technology, new media, TMT, clean technologies, consumer service and healthcare. Portfolio companies include Meituan.com, Kaixin001.com, Gogo.com, redbaby.com, MasaMaso.com, and Velo City.
Northern Light Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Figo Zhang
Partner
|
|||
Feng Deng
Founding General Partner
|
|||
Lixin Li
Managing Director
|
|||
Lu Lin
Executive Director
|
|||
Pandy Song
Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Li Shuai invest in?
Li Shuai invests primarily in Robotics, Therapeutics and Biotechnology startups, most often at Angel and Series D stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Li Shuai?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Li Shuai last invest?
The most recent investment recorded for Li Shuai closed in Sep 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
